Cargando…
The Treatment of Vestibular Migraine: A Narrative Review
Vestibular migraine (VM) is one of the most debilitating chronic diseases that is currently underdiagnosed and undertreated. The treatment of VM is a dynamic and rapidly advancing area of research. New developments in this field have the potential to improve the diagnosis and provide more individual...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887465/ https://www.ncbi.nlm.nih.gov/pubmed/33623258 http://dx.doi.org/10.4103/aian.AIAN_591_19 |
_version_ | 1783651988895956992 |
---|---|
author | Shen, Youjin Qi, Xiaokun Wan, Tingyu |
author_facet | Shen, Youjin Qi, Xiaokun Wan, Tingyu |
author_sort | Shen, Youjin |
collection | PubMed |
description | Vestibular migraine (VM) is one of the most debilitating chronic diseases that is currently underdiagnosed and undertreated. The treatment of VM is a dynamic and rapidly advancing area of research. New developments in this field have the potential to improve the diagnosis and provide more individualized treatments for this condition. In this review, we discussed the progress of evidence-based treatment of VM, including pharmacotherapy and nonmedical methods. A search of the literature was conducted up to September 2019. In order to control or cure VM, patients should follow three steps. First, patients should comply with diet and behavioral medication; Second, during the attack of VM, patients should take medicine to control the symptoms. These acute attack treatment of VM consists of antiemetic medications (e.g., dimenhydrinate and benzodiazepines), anti-vertigo medicine, and analgesics (e.g. triptans). Third, prophylactic medicine (e.g., propranolol, topiramate, valproic aid, lamotrigine, and flunarizine) can be used to reduce the frequency and severity of VM attack. Also, vestibular rehabilitation (VR) treatment should be considered for all VM. Meanwhile, we also propose to establish a culture of prevention which is essential for reducing the personal, social and economic burden of VM. |
format | Online Article Text |
id | pubmed-7887465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-78874652021-02-22 The Treatment of Vestibular Migraine: A Narrative Review Shen, Youjin Qi, Xiaokun Wan, Tingyu Ann Indian Acad Neurol AIAN Review Vestibular migraine (VM) is one of the most debilitating chronic diseases that is currently underdiagnosed and undertreated. The treatment of VM is a dynamic and rapidly advancing area of research. New developments in this field have the potential to improve the diagnosis and provide more individualized treatments for this condition. In this review, we discussed the progress of evidence-based treatment of VM, including pharmacotherapy and nonmedical methods. A search of the literature was conducted up to September 2019. In order to control or cure VM, patients should follow three steps. First, patients should comply with diet and behavioral medication; Second, during the attack of VM, patients should take medicine to control the symptoms. These acute attack treatment of VM consists of antiemetic medications (e.g., dimenhydrinate and benzodiazepines), anti-vertigo medicine, and analgesics (e.g. triptans). Third, prophylactic medicine (e.g., propranolol, topiramate, valproic aid, lamotrigine, and flunarizine) can be used to reduce the frequency and severity of VM attack. Also, vestibular rehabilitation (VR) treatment should be considered for all VM. Meanwhile, we also propose to establish a culture of prevention which is essential for reducing the personal, social and economic burden of VM. Wolters Kluwer - Medknow 2020 2020-02-11 /pmc/articles/PMC7887465/ /pubmed/33623258 http://dx.doi.org/10.4103/aian.AIAN_591_19 Text en Copyright: © 2006 - 2020 Annals of Indian Academy of Neurology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | AIAN Review Shen, Youjin Qi, Xiaokun Wan, Tingyu The Treatment of Vestibular Migraine: A Narrative Review |
title | The Treatment of Vestibular Migraine: A Narrative Review |
title_full | The Treatment of Vestibular Migraine: A Narrative Review |
title_fullStr | The Treatment of Vestibular Migraine: A Narrative Review |
title_full_unstemmed | The Treatment of Vestibular Migraine: A Narrative Review |
title_short | The Treatment of Vestibular Migraine: A Narrative Review |
title_sort | treatment of vestibular migraine: a narrative review |
topic | AIAN Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887465/ https://www.ncbi.nlm.nih.gov/pubmed/33623258 http://dx.doi.org/10.4103/aian.AIAN_591_19 |
work_keys_str_mv | AT shenyoujin thetreatmentofvestibularmigraineanarrativereview AT qixiaokun thetreatmentofvestibularmigraineanarrativereview AT wantingyu thetreatmentofvestibularmigraineanarrativereview AT shenyoujin treatmentofvestibularmigraineanarrativereview AT qixiaokun treatmentofvestibularmigraineanarrativereview AT wantingyu treatmentofvestibularmigraineanarrativereview |